Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Factors of Outcome in Patient With Malignant Gastrointestinal Bleeding Treated With a Novel Hemostatic Power

NCT03066700 is registered in ClinicalTrials.gov with King Chulalongkorn Memorial Hospital as lead sponsor.

NCT NCT03066700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03066700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Factors of Outcome in Patient With Malignant Gastrointestinal Bleeding Treated With a Novel Hemostatic Power
Lead sponsor
King Chulalongkorn Memorial Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2017
Completion date
August 31, 2017
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

death